Changes in erythrocyte membrane fatty acids during a clinical trial of eicosapentaenoic acid (EPA) supplementation in schizophrenia

Metabolic Brain Disease

Volumn 24, Issue 4, 2009, Pages 659-672

  Van Rensburg, Susan J ^a,d   Smuts, Cornelius M ^b   Hon, Dinie ^c   Kidd, Martin ^a   Van Der Merwe, Sulene ^a   Myburgh, Christo ^a   Oosthuizen, Piet ^a   Emsley, Robin ^a  

^a STELLENBOSCH UNIVERSITY   (South Africa)

^b NORTH WEST UNIVERSITY   (South Africa)

^c CAPE PENINSULA UNIVERSITY OF TECHNOLOGY   (South Africa)

^d STELLENBOSCH UNIVERSITY   (South Africa)

Author keywords

Dyskinesia; Eicosapentaenoic acid; Fatty acids; Schizophrenia

Indexed keywords

DOCOSAHEXAENOIC ACID; FATTY ACID; ICOSAPENTAENOIC ACID; LINOLEIC ACID; MONOUNSATURATED FATTY ACID; OMEGA 3 FATTY ACID; OMEGA 6 FATTY ACID; PLACEBO; SATURATED FATTY ACID;

ADULT; ARTICLE; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CORRELATION ANALYSIS; DIET SUPPLEMENTATION; DOUBLE BLIND PROCEDURE; DYSKINESIA; ERYTHROCYTE MEMBRANE; EXTRAPYRAMIDAL SYMPTOM; FATTY ACID ANALYSIS; FEMALE; HUMAN; MALE; MENTAL DISEASE; POSITIVE AND NEGATIVE SYNDROME SCALE; RANDOMIZED CONTROLLED TRIAL; SCHIZOPHRENIA; SCORING SYSTEM; SEX DIFFERENCE; SINGLE BLIND PROCEDURE;

ADOLESCENT; ADULT; AGED; ALPHA-LINOLENIC ACID; DIETARY SUPPLEMENTS; DISABILITY EVALUATION; DOCOSAHEXAENOIC ACIDS; DYSKINESIAS; EICOSAPENTAENOIC ACID; ERYTHROCYTES; FATTY ACIDS; FATTY ACIDS, MONOUNSATURATED; FEMALE; HUMANS; MALE; MEMBRANE LIPIDS; MIDDLE AGED; NEUROPSYCHOLOGICAL TESTS; SCHIZOPHRENIA; TREATMENT OUTCOME; UP-REGULATION; YOUNG ADULT;

EID: 74449084911     PISSN: 08857490     EISSN: None     Source Type: Journal    
DOI: 10.1007/s11011-009-9160-7     Document Type: Article

References (36)

1. O Christensen E Christensen 1988 Fat consumption and schizophrenia Acta Psychiatr. Scand. 78 587 591 10.1111/j.1600-0447.1988.tb06388.x 1:STN:280:DyaL1M7mtlOqtA%3D%3D 3232536
2. R Condray JK Yao SR Steinhauer DP van Kammen RD Reddy LA Morrow 2008 Semantic memory in schizophrenia: association with cell membrane essential fatty acids Schizophr Res. 106 13 28 10.1016/j.schres.2008.03.009 18929465
3. M De Hert V Schreurs D Vancampfort R Van Winkel 2009 Metabolic syndrome in people with schizophrenia: a review World Psychiatry 8 15 22
4. R Emsley C Myburgh P Oosthuizen SJ Van Rensburg 2002 Randomized placebo-controlled study of ethyl-eicosapentaenoic acid as supplemental treatment in schizophrenia Am. J. Psychiatry 159 1596 1598 10.1176/appi.ajp.159. 9.1596 12202284 (Pubitemid 35006744)
5. R Emsley P Oosthuizen SJ Van Rensburg 2003 Clinical Potential of Omega-3-Fatty Acids in the treatment of schizophrenia CNS Drugs 17 1081 1091 10.2165/00023210-200317150-00003 1:CAS:528:DC%2BD2cXmsVSrsA%3D%3D 14661986 (Pubitemid 38021394)
6. R Emsley DJ Niehaus L Koen PP Oosthuizen HJ Turner P Carey SJ Van Rensburg JS Maritz H Murck 2006 The effects of eicosapentaenoic acid in tardive dyskinesia: a randomized, placebo-controlled trial Schizophr Res. 84 112 20 10.1016/j.schres.2006.03.023 16632329 (Pubitemid 44255716)
7. DR Evans VV Parikh MM Khan C Coussons PF Buckley SP Mahadik 2003 Red blood cell membrane essential fatty acid metabolism in early psychotic patients following antipsychotic drug treatment Prostaglandins Leukot Essent Fatty Acids. 69 393 399 10.1016/j.plefa.2003.08.010 1:CAS:528:DC%2BD3sXptVersbw%3D 14623492 (Pubitemid 37464048)
8. AA Farooqui WY Ong LA Horrocks 2006 Inhibitors of brain phospholipase A2 activity: their neuropharmacological effects and therapeutic importance for the treatment of neurologic disorders Pharmacol Rev. 58 591 620 10.1124/pr.58.3.7 1:CAS:528:DC%2BD28XhtVOhtLfK 16968951 (Pubitemid 44403685)
9. WS Fenton F Dickerson J Boronow JR Hibbeln MA Knable 2001 Placebo-controlled trial of omega-3 fatty acid (ethyl eicosapentaenoic acid) supplementation for residual symptoms and cognitive impairment in schizophrenia Am. J. Psychiatry 158 2071 2074 10.1176/appi.ajp.158.12.2071 1:STN:280:DC%2BD3Mnot1akug%3D%3D 11729030 (Pubitemid 33104119)
10. 2 from human epidermis Biochem. Soc. Trans. 19 91S 1:CAS:528:DyaK3MXksVCrtrY%3D 1889683
11. J Folch M Lees GH Sloane-Stanley 1957 A simple method for the isolation and purification of total lipids from animal tissues J. Biol. Chem. 226 497 509 1:STN:280:DyaG2s%2FnsFCjtw%3D%3D 13428781
12. 2 activity in schizophrenia: a replication study Biol Psychiatry 28 495 501 1:CAS:528:DyaK3MXhsVSqsr8%3D 2223919
13. Gebauer SK, Psota TL, Harris WS, Kris-Etherton PM (2006) n-3 fatty acid dietary recommendations and food sources to achieve essentiality and cardiovascular benefits. Am. J. Clin. Nutr. 83(6 Suppl):1526S-1535S
14. Horrobin DF (1999) The phospholipid concept of psychiatric disorders and its relationship to the neurodevelopmental concept of schizophrenia. In: Peet M, Glen I, Horrobin DF (eds) Phospholipid spectrum disorder in psychiatry. Marius, Lancashire, pp 3-20
15. DF Horrobin K Jenkins CN Bennett WW Christie 2002 Eicosapentaenoic acid and arachidonic acid: collaboration and not antagonism is the key to biological understanding Prostagland Leurkotr Essent Fatty Acids 66 83 90 10.1054/plef.2001.0338 1:CAS:528:DC%2BD38XlsVGhuro%3D (Pubitemid 34717690)
16. MM Khan DR Evans V Gunna RE Scheffer VV Parikh SP Mahadik 2002 Reduced erythrocyte membrane essential fatty acids and increased lipid peroxides in schizophrenia at the never-medicated first-episode of psychosis and after years of treatment with antipsychotics Schizophr. Res. 58 1 10 10.1016/S0920-9964(01) 00334-6 12363384 (Pubitemid 35287278)
17. RF Kemperman M Veurink T van der Wal H Knegtering R Bruggeman MR Fokkema IP Kema J Korf FA Muskiet 2006 Low essential fatty acid and B-vitamin status in a subgroup of patients with schizophrenia and its response to dietary supplementation Prostaglandins Leukot Essent Fatty Acids. 74 75 85 10.1016/j.plefa.2005.11.004 1:CAS:528:DC%2BD28XksValsw%3D%3D 16384692 (Pubitemid 43082132)
18. Kruger M, Langenhoven M, Faber M (1991) Fatty acid and amino acid composition tables. Supplement to MRC Food Composition Tables. MRC, Parow
19. J Levine Z Stahl BA Sela V Ruderman O Shumaico I Babushkin Y Osher Y Bersudsky RH Belmaker 2006 Homocysteine-reducing strategies improve symptoms in chronic schizophrenic patients with hyperhomocysteinemia Biol Psychiatry. 60 265 9 10.1016/j.biopsych.2005.10.009 1:CAS:528:DC%2BD28Xntl2ms7c%3D 16412989 (Pubitemid 44093437)
20. RK McNamara JA Able R Jandacek T Rider P Tso 2009 Chronic risperidone treatment preferentially increases rat erythrocyte and prefrontal cortex omega-3 fatty acid composition: evidence for augmented biosynthesis Schizophr Res. 107 150 157 10.1016/j.schres.2008.09.027 18993032
21. JE Mellor JDE Laugharne M Peet 1995 Schizophrenic symptoms and dietary intake of n-3 fatty acids Schizophr. Res. 18 85 86 10.1016/0920-9964(95)00084-4 1:STN:280:DyaK2s%2FotlWqsA%3D%3D 8929766
22. K Ohara 2007 The n-3 polyunsaturated fatty acid/dopamine hypothesis of schizophrenia Prog Neuropsychopharmacol Biol Psychiatry. 31 469 74 10.1016/j.pnpbp.2006.11.013 1:CAS:528:DC%2BD2sXhsFOjtbo%3D 17184889 (Pubitemid 46209444)
23. M Peet J Brind CN Ramchand S Shah GK Vankar 2001 Two double-blind placebo-controlled pilot studies of eicosapentaenoic acid in the treatment of schizophrenia Schizophr. Res. 49 243 251 10.1016/S0920-9964(00)00083-9 1:STN:280:DC%2BD3M3msVyqtg%3D%3D 11356585 (Pubitemid 32453225)
24. M Peet S Shah K Selvam CN Ramchand 2004 Polyunsaturated fatty acid levels in red cell membranes of unmedicated schizophrenic patients World J Biol Psychiatry. 5 92 99 10.1080/15622970410029917 15179668
25. M Peet 2008 Omega-3 polyunsaturated fatty acids in the treatment of schizophrenia Isr J Psychiatry Relat Sci. 45 19 25 18587166
26. BK Puri BM Ross IH Treasaden 2008 Increased levels of ethane, a non-invasive, quantitative, direct marker of n-3 lipid peroxidation, in the breath of patients with schizophrenia Prog Neuropsychopharmacol Biol Psychiatry. 32 858 862 10.1016/j.pnpbp.2008.01.001 1:CAS:528:DC%2BD1cXislalt7c%3D 18262322 (Pubitemid 351320545)
27. PK Ranjekar A Hinge MV Hegde M Ghate A Kale S Sitasawad UV Wagh VB Debsikdar SP Mahadik 2003 Decreased antioxidant enzymes and membrane essential polyunsaturated fatty acids in schizophrenic and bipolar mood disorder patients Psychiatry Res. 121 109 122 10.1016/S0165-1781(03)00220-8 1:CAS:528: DC%2BD3sXptlyntrg%3D 14656446 (Pubitemid 37500981)
28. RD Reddy MS Keshavan JK Yao 2004 Reduced red blood cell membrane essential polyunsaturated fatty acids in first episode schizophrenia at neuroleptic-naive baseline Schizophr Bull. 30 901 11 15957200
29. EY Sivrioglu S Kirli D Sipahioglu B Gursoy E Sarandöl 2007 The impact of omega-3 fatty acids, vitamins E and C supplementation on treatment outcome and side effects in schizophrenia patients treated with haloperidol: an open-label pilot study Prog Neuropsychopharmacol Biol Psychiatry. 31 1493 1499 10.1016/j.pnpbp.2007.07.004 1:CAS:528:DC%2BD2sXpvF2rtrY%3D 17688987 (Pubitemid 47302571)
30. T Sumiyoshi M Matsui H Itoh Y Higuchi H Arai C Takamiya M Kurachi 2008 Essential polyunsaturated fatty acids and social cognition in schizophrenia Psychiatry Res. 157 87 93 10.1016/j.psychres.2006.05.025 1:CAS:528: DC%2BD2sXhsVWisLzK 17976738 (Pubitemid 350166534)
31. KS Vaddadi CJ Gilleard E Soosai AK Polonowita RA Gibson GD Burrows 1996 Schizophrenia, tardive dyskinesia and essential fatty acids Schizophr. Res. 20 287 294 10.1016/0920-9964(95)00095-X 1:STN:280:DyaK28visFCisQ%3D%3D 8827855 (Pubitemid 26232973)
32. PJ Van Jaarsveld CM Smuts HY Tichelaar M Kruger AJS Benadé 2000 Effect of palm oil on plasma lipoprotein concentrations and plasma low-density lipoprotein composition in non-human primates Int. J. Food Sci. Nutr. 51 S21 S30 10.1080/096374800750049549 11271853
33. Y Von Hausswolff-Juhlin M Bjartveit E Lindström P Jones 2009 Schizophrenia and physical health problems Acta Psychiatr Scand Suppl 438 15 21 10.1111/j.1600-0447.2008.01309.x
34. JK Yao S Leonard RD Reddy 2000 Membrane phospholipid abnormalities in postmortem brains from schizophrenic patients Schizophr. Res. 42 7 17 10.1016/S0920-9964(99)00095-X 1:STN:280:DC%2BD3c7ntlKitw%3D%3D 10706981 (Pubitemid 30116755)
35. JK Yao JA Stanley RD Reddy MS Keshavan JW Pettegrew 2002 Correlations between peripheral polyunsaturated fatty acid content and in vivo membrane phospholipid metabolites Biol. Psychiatry 52 823 830 10.1016/S0006-3223(02) 01397-5 1:CAS:528:DC%2BD38Xns1SjsLw%3D 12372654
36. JK Yao S Magan AF Sonel JA Gurklis R Sanders RD Reddy 2004 Effects of omega-3 fatty acid on platelet serotonin responsivity in patients with schizophrenia Prostaglandins Leukot Essent Fatty Acids. 71 171 6 10.1016/j.plefa.2004.03.011 1:CAS:528:DC%2BD2cXlslyjs78%3D 15253886 (Pubitemid 38903062)